{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:09:08Z","timestamp":1788480548485,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017957","name":"Health Commission of Guizhou Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017957","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.bcp.2024.116563","type":"journal-article","created":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T23:57:11Z","timestamp":1727827031000},"page":"116563","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"P1","title":["PCSK9 inhibitor attenuates cardiac fibrosis in reperfusion injury rat by suppressing inflammatory response and TGF-\u03b21\/Smad3 pathway"],"prefix":"10.1016","volume":"230","author":[{"given":"Qing","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhina","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5903-1272","authenticated-orcid":false,"given":"Guangwei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bcp.2024.116563_b0005","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1161\/CIRCULATIONAHA.121.056272","article-title":"Novel cardiokine GDF3 predicts adverse fibrotic remodeling after myocardial infarction","volume":"147","author":"Masurkar","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2024.116563_b0010","doi-asserted-by":"crossref","unstructured":"Shen S C, Xu J, Cheng C, et al. Macrophages promote the transition from myocardial ischemia reperfusion injury to cardiac fibrosis in mice through GMCSF\/CCL2\/CCR2 and phenotype switching. 2024, 45(5): 959-74.","DOI":"10.1038\/s41401-023-01222-3"},{"issue":"3","key":"10.1016\/j.bcp.2024.116563_b0015","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.tem.2023.10.010","article-title":"Regulated cell death in myocardial ischemia-reperfusion injury","volume":"35","author":"Xiang","year":"2024","journal-title":"Trends Endocrinol. Metabol. TEM"},{"issue":"1","key":"10.1016\/j.bcp.2024.116563_b0020","article-title":"Exercise benefits in cardiovascular disease: beyond attenuation of traditional risk factors","volume":"15","author":"Carmen","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"issue":"6","key":"10.1016\/j.bcp.2024.116563_b0025","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000000697","article-title":"Pediatric post-cardiac arrest care: A scientific statement from the American Heart Association","volume":"140","author":"Topjian","year":"2019","journal-title":"Circulation: Off. J. Am. Heart Assoc."},{"key":"10.1016\/j.bcp.2024.116563_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.matbio.2018.01.013","article-title":"Extracellular matrix remodeling and cardiac fibrosis","author":"Li","year":"2018","journal-title":"Matrix Biol."},{"issue":"9","key":"10.1016\/j.bcp.2024.116563_b0035","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00011-017-1060-4","article-title":"Role of the immune system in cardiac tissue damage and repair following myocardial infarction","volume":"66","author":"Saparov","year":"2017","journal-title":"Inflamm. Res: Off. J. Eur. Histamine Res. Soc. [et Al]"},{"key":"10.1016\/j.bcp.2024.116563_b0040","article-title":"TGF-\u03b21\/SMAD3 regulates programmed cell death 5 that suppresses cardiac fibrosis post-myocardial infarction by inhibiting HDAC3","author":"Lin","year":"2023","journal-title":"Circul. Res. J. Am. Heart Assoc."},{"issue":"7","key":"10.1016\/j.bcp.2024.116563_b0045","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41569-020-00504-1","article-title":"Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches","volume":"18","author":"L\u00f3PEZ","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"issue":"7","key":"10.1016\/j.bcp.2024.116563_b0050","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.7150\/thno.78736","article-title":"Hypoxia induces M2 macrophages to express VSIG4 and mediate cardiac fibrosis after myocardial infarction","volume":"13","author":"Wang","year":"2023","journal-title":"Theranostics"},{"issue":"16","key":"10.1016\/j.bcp.2024.116563_b0055","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.jacc.2013.07.056","article-title":"Targeting the proprotein convertase subtilisin\/kexin type 9 for the treatment of dyslipidemia and atherosclerosis","volume":"62","author":"Urban","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.bcp.2024.116563_b0060","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00395-017-0619-0","article-title":"Physiological and therapeutic regulation of PCSK9 activity in cardiovascular disease","volume":"112","author":"Glerup","year":"2017","journal-title":"Basic Res. Cardiol."},{"issue":"13","key":"10.1016\/j.bcp.2024.116563_b0065","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1161\/CIRCULATIONAHA.115.018531","article-title":"Circulating proprotein convertase subtilisin\/Kexin Type 9 (PCSK9) predicts future risk of cardiovascular events independently of established risk factors","volume":"133","author":"Leander","year":"2016","journal-title":"Circulation"},{"issue":"32","key":"10.1016\/j.bcp.2024.116563_b0070","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1093\/eurheartj\/ehab431","article-title":"PCSK9 deficiency rewires heart metabolism and drives heart failure with preserved ejection fraction","volume":"42","author":"da Dalt","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bcp.2024.116563_b0075","doi-asserted-by":"crossref","first-page":"e069116","DOI":"10.1136\/bmj-2021-069116","article-title":"PCSK9 inhibitors and ezetimibe with or without statin therapy for cardiovascular risk reduction: a systematic review and network meta-analysis","volume":"377","author":"Khan","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.bcp.2024.116563_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.mvr.2022.104371","article-title":"PCSK9 inhibition protects against myocardial ischemia-reperfusion injury via suppressing autophagy","volume":"142","author":"Huang","year":"2022","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.bcp.2024.116563_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115996","article-title":"PCSK9 regulates myofibroblast transformation through the JAK2\/STAT3 pathway to regulate fibrosis after myocardial infarction","volume":"220","author":"Bao","year":"2024","journal-title":"Biochem. Pharmacol."},{"issue":"17","key":"10.1016\/j.bcp.2024.116563_b0090","first-page":"2204","article-title":"Myocardial interstitial fibrosis in nonischemic heart disease, Part 3\/4","volume":"75","author":"D\u00edez","year":"2020","journal-title":"JACC Focus Seminar - ScienceDirect"},{"key":"10.1016\/j.bcp.2024.116563_b0095","doi-asserted-by":"crossref","unstructured":"Talman V, Ruskoaho H J C, Research T. Cardiac fibrosis in myocardial infarction\u2014from repair and remodeling to regeneration. 2016, 365(3): 563-81.","DOI":"10.1007\/s00441-016-2431-9"},{"key":"10.1016\/j.bcp.2024.116563_b0100","doi-asserted-by":"crossref","unstructured":"Fu X, Khalil H, Kanisicak O, et al. Specialized fibroblast differentiated states underlie scar formation in the infarcted mouse heart. 2018, 128(5):.","DOI":"10.1172\/JCI98215"},{"issue":"4","key":"10.1016\/j.bcp.2024.116563_b0105","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/s41581-022-00675-9","article-title":"Exercise and chronic kidney disease: potential mechanisms underlying the physiological benefits","volume":"19","author":"Bishop","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"issue":"7","key":"10.1016\/j.bcp.2024.116563_b0110","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jacc.2021.05.052","article-title":"Is myocardial fibrosis the missing link between prematurity, cardiac remodeling, and long-term cardiovascular outcomes?","volume":"78","author":"Geva","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bcp.2024.116563_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106578","article-title":"EZH2 serves as a promising therapeutic target for fibrosis","volume":"137","author":"Zhang","year":"2023","journal-title":"Bioorg. Chem."},{"issue":"7","key":"10.1016\/j.bcp.2024.116563_b0120","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/1440-1681.13271","article-title":"Curcumin attenuates endothelial cell fibrosis through inhibiting endothelial-interstitial transformation","volume":"47","author":"Chen","year":"2020","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"7","key":"10.1016\/j.bcp.2024.116563_b0125","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1093\/cvr\/cvab205","article-title":"Loss of Yap\/Taz in cardiac fibroblasts attenuates adverse remodelling and improves cardiac function","volume":"118","author":"Mia","year":"2022","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.bcp.2024.116563_b0130","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00441-016-2431-9","article-title":"Cardiac fibrosis in myocardial infarction-from repair and remodeling to regeneration","volume":"365","author":"Talman","year":"2016","journal-title":"Cell Tissue Res."},{"issue":"6342","key":"10.1016\/j.bcp.2024.116563_b0135","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1126\/science.aam7928","article-title":"Inflammation and metabolism in tissue repair and regeneration","volume":"356","author":"Eming","year":"2017","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.bcp.2024.116563_b0140","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1093\/cvr\/cvz313","article-title":"PCSK9 and inflammation: role of shear stress, pro-inflammatory cytokines, and LOX-1","volume":"116","author":"Ding","year":"2020","journal-title":"Cardiovasc. Res."},{"issue":"2","key":"10.1016\/j.bcp.2024.116563_b0145","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/hep.29491","article-title":"Inflammasome-mediated inflammation and fibrosis: It is more than just the IL-1\u03b2","volume":"67","author":"Amir","year":"2018","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.bcp.2024.116563_b0150","doi-asserted-by":"crossref","first-page":"e1847","DOI":"10.1038\/cddis.2015.206","article-title":"Chop deficiency prevents UUO-induced renal fibrosis by attenuating fibrotic signals originated from Hmgb1\/TLR4\/NF\u03baB\/IL-1\u03b2 signaling","volume":"6","author":"Zhang","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2024.116563_b0155","article-title":"Inflammasomes and fibrosis","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"issue":"13","key":"10.1016\/j.bcp.2024.116563_b0160","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1093\/cvr\/cvy128","article-title":"PCSK9 expression in the ischaemic heart and its relationship to infarct size, cardiac function, and development of autophagy","volume":"114","author":"Ding","year":"2018","journal-title":"Cardiovasc. Res."},{"issue":"12","key":"10.1016\/j.bcp.2024.116563_b0165","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s12012-022-09771-5","article-title":"PCSK9 knockdown can improve myocardial ischemia\/reperfusion injury by inhibiting autophagy","volume":"22","author":"Huang","year":"2022","journal-title":"Cardiovasc. Toxicol."},{"issue":"2","key":"10.1016\/j.bcp.2024.116563_b0170","doi-asserted-by":"crossref","first-page":"531","DOI":"10.7150\/thno.80289","article-title":"SIRT3 mediates the effects of PCSK9 inhibitors on inflammation, autophagy, and oxidative stress in endothelial cells","volume":"13","author":"D'Onofrio","year":"2023","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.bcp.2024.116563_b0175","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41569-018-0107-8","article-title":"PCSK9 inhibitors: clinical evidence and implementation","volume":"16","author":"Sabatine","year":"2019","journal-title":"Nat. Rev. Cardiol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522400563X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522400563X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T03:02:45Z","timestamp":1732849365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000629522400563X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":35,"alternative-id":["S000629522400563X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116563","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PCSK9 inhibitor attenuates cardiac fibrosis in reperfusion injury rat by suppressing inflammatory response and TGF-\u03b21\/Smad3 pathway","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116563","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116563"}}